Business Context and Reporting Period
Company: SONO-TEK CORPORATION
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: August 31, 1995
Business Overview: The Company manufactures and markets SonoFlux Systems for printed circuit board manufacturing and Nozzle Systems. It is currently developing a new "Wafer Coating System" for the semiconductor industry.
Key Financial Metrics
| Metric | Six Months Ended Aug 31, 1995 | Three Months Ended Aug 31, 1995 |
|---|---|---|
| Net Sales | $1,349,508 | $613,549 |
| Gross Profit | $781,490 | $376,742 |
| Gross Margin | 58% | 61% |
| Operating Income | $65,481 | $54,833 |
| Net Income | $65,394 | $38,368 |
| Earnings Per Share | $0.02 | $0.01 |
| Cash and Equivalents (Aug 31, 1995) | $47,330 | |
| Working Capital (Aug 31, 1995) | $221,029 | |
| Total Debt (Current + Long Term) | $833,159 | |
| Shareholders' Deficiency | ($283,601) |
Material Changes vs. Prior Period
- Revenue: Net sales decreased 3.5% for the six-month period ($1.35M vs. $1.40M) and 10.3% for the three-month period ($613.5K vs. $684K). The decline was driven by a $251,000 drop in SonoFlux Systems sales, partially offset by a $202,000 increase in Nozzle Systems sales.
- Profitability: The Company returned to profitability, reporting a net income of $65,394 for the six months ended August 31, 1995, compared to a net loss of $159,381 in the prior year period. Gross margin improved significantly from 46% to 58% due to a favorable product mix shift toward higher-margin Nozzle Systems and reduced production overhead.
- Expenses: Operating expenses decreased by $57,627 for the six-month period. General and administrative costs dropped $65,525 due to reduced reserves for doubtful accounts and lower professional fees. Marketing costs fell $43,828 due to reduced travel expenses as the company focused on North American markets.
- Other Income: Interest and other income increased to $32,933 from $107, primarily due to funding received from SEMATECH for joint development work.
Outlook, Risks, and Contingencies
- Going Concern Doubt: Management explicitly states that substantial doubt exists regarding the Company's ability to continue as a going concern. The Company has a shareholders' deficiency of $283,601 and has historically struggled with working capital, leading to delayed vendor payments and collection agency involvement.
- Debt Obligations: The Company failed to make three of four scheduled interest payments on convertible secured subordinated promissory notes during Fiscal 1995. While noteholders agreed to waive default rights through February 15, 1996, the Company faces significant debt maturities in November 1996 (bank debt) and August 1997 (convertible notes).
- Product Development: The Company is relying on the success of two new products to improve liquidity: the SonoFlux 9500 (shipped since May 1995) and the Wafer Coating System (anticipated shipment in Q4 Fiscal 1996).
- Liquidity Strategy: In February 1995, the Company sold 333,333 shares of common stock for $100,000 to raise capital. Management anticipates that new product sales will improve the working capital position, though no assurances are given.
Investor Verification Checklist
- Debt Default Status: Verify the current status of the waiver agreement with noteholders regarding missed interest payments and the risk of acceleration of debt.
- Cash Runway: Assess whether the current cash balance of $47,330 and operating cash flow of $12,337 (six months) are sufficient to cover upcoming debt maturities and operational costs without further dilution.
- Product Adoption: Confirm actual sales traction for the new SonoFlux 9500 and the timeline for the Wafer Coating System, as these are critical to the turnaround strategy.
- Vendor Relations: Investigate the extent of vendor collection actions and whether supply chain disruptions pose an immediate threat to production.
- Equity Dilution: Monitor for potential future equity issuances required to meet debt obligations or fund operations, given the existing shareholders' deficiency.